跳至主要内容
临床试验/NCT07667829
NCT07667829尚未招募不适用

Comparison of the Efficacy and Safety of Dopamine, Norepinephrine and Epinephrine in the Treatment of Pulmonary Hypertensive Crisis Under Hemodynamic Monitoring

China National Center for Cardiovascular Diseases3 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2026年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
75
试验地点
3

研究概览

简要总结

Comparison of the efficacy and safety of three vasoactive agents-dopamine, norepinephrine, and epinephrine-in the treatment of patients with pulmonary hypertension crisis: prospective, randomised controlled trial monitored by haemodynamic monitoring

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old;
  • Signed informed consent form;
  • Confirmed diagnosis of arterial pulmonary hypertension (PAH) and/or chronic thromboembolic pulmonary hypertension (CTEPH);
  • Presenting with manifestations of pulmonary hypertensive crisis;
  • Receiving both diagnosis and treatment in-hospital;
  • No intravenous administration of the vasopressor drugs (including dopamine, norepinephrine, and epinephrine) under study at enrollment.

排除标准

  • At SCAI stage D or stage E ;
  • Patients who only receive a diagnosis but no treatment in the hospital;
  • Uncontrolled hyperthyroidism;
  • Complicated with angle-closure glaucoma;
  • Hypersensitivity to the study drug;
  • Ongoing use of halogenated hydrocarbon general anesthetics such as cyclopropane and halothane;
  • Ongoing use of monoamine oxidase inhibitor (MAOI) antidepressants or anti-Parkinson drugs (phenelzine, tranylcypromine, isocarboxazid, moclobemide);
  • Already receiving the vasopressor drugs (dopamine, norepinephrine, epinephrine) under study at enrollment.

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Qing Gu

Study Chair

Chinese Academy of Medical Sciences, Fuwai Hospital

研究点 (3)

Loading locations...

相似试验

Vasopressor Agents in Pulmonary Hypertension Crisis | 临床试验